Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Clinical Pharmacokinetics - United Kingdom
doi 10.2165/11599820-000000000-00000
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2012
Authors
Publisher
Springer Science and Business Media LLC